Lindsay Androski
-
Warminster Biopharma Firm Ends $285M Licensing Deal with Chinese Company
Warminster-based Arbutus Biopharma has ended a 4-year licensing deal worth up to $285 million with Qilu Pharmaceuticals, a Chinese drugmaker, writes John George for the…
-
Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters
Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while continuing its pursuit of a hepatitis…
Founding Partners
Advertisement
Affiliate Partners
